Regional hyperthermia (RHT) combined with gemcitabine (G) plus cisplatin (P) in patients (pts) with advanced pancreatic adenocarcinoma (APC)

被引：0
|
作者：
Tschoep, K. E. [1 ]
Milani, V. [1 ]
Lindner, L. H. [1 ]
Boeck, S. [1 ]
Berger, F. [2 ]
Dieterle, N. [1 ]
Abdel-Rahman, S. [1 ]
Salat, C. [3 ]
Issels, R. D. [1 ]
机构：
[1] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Klin Nukl Med, D-8000 Munich, Germany
[3] Hamatoonkol Schwerpunktpraxis & Tagesklin, Munich, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C), and paricalcitol (P)neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).
    Borazanci, Erkut Hasan
    Jameson, Gayle S.
    Snyder, Courtney
    Tsai, Frank Yung-Chin
    Gordon, Michael S.
    Sharma, Sunil
    Guarnieri, Carol
    Thosani, Amar
    Rahmanuddin, Syed
    Korn, Ronald Lee
    Sckolnik, Steven
    Salontai, Sharon
    Wyman, Rachel
    Haag, Susan
    Gosselin, Kevin
    Von Hoff, Daniel D.
    Amini, Albert
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Gemcitabine (G) fixed-lose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC)
    Munoz Llarena, A.
    Mane, J.
    Lopez-Vivanco, G.
    Ruiz de Lobera, A.
    Sancho, A.
    Iruarrizaga, E.
    Arruti, M.
    Marrodan, I.
    Fuente, N.
    Ballesteros, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [23] Phase II study of gefitinib and docetaxel as salvage therapy in patients (pts) with advanced pancreatic adenocarcinoma (APC).
    Shadad, F.
    Matin, K.
    Evans, T. L.
    Volkin, R. L.
    Kiefer, G. J.
    Schlesselman, J. J.
    Cai, C.
    Schmotzer, A.
    Dranko, S.
    Ramanathan, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 207S - 207S
  • [24] Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors
    Subbiah, V.
    Combest, A.
    Grilley-Olson, J.
    Sharma, N.
    Andrews, E.
    Bobe, I.
    Balkissoon, J.
    Camp, A.
    Masada, A.
    Reitsma, D.
    Bazhenova, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S118 - S119
  • [25] A dose-escalation study of gemcitabine (Gem) plus oxaliplatin (Ox) in combination with imatinib in patients (pts) with gemcitabine-refractory advanced pancreatic adenocarcinoma (PC)
    Starling, N.
    Hawkes, E. A.
    Chau, I.
    Watkins, D. J.
    Thomas, J.
    Webb, J.
    Brown, G.
    Thomas, K.
    Oates, J. R.
    Cunningham, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial
    不详
    LANCET ONCOLOGY, 2008, 9 (01) : 39 - 44
  • [27] Gemcitabine combined with oxaliplatin is safe and effective in patients with previously untreated advanced pancreatic adenocarcinoma
    Baize, N
    Abu Shalaa, A
    Berthier, F
    Demarquay, JFO
    Bernard, JL
    Rahiu, A
    Piche, T
    Huet, PM
    Ran, A
    Caroli-Bosc, FX
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (10): : 1006 - 1009
  • [28] A phase II pilot trial of nivolumab plus albumin bound paclitaxel plus paricalcitol plus cisplatin plus gemcitabine (NAPPCG) in patients (pts) with previously untreated metastatic pancreatic ductal adenocarcinoma.
    Borazanci, Erkut Hasan
    Jameson, Gayle S.
    Borad, Mitesh J.
    Ramanathan, Ramesh K.
    Korn, Ronald Lee
    Caldwell, Lana
    Ansaldo, Karen
    Hendrickson, Kristin
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [29] Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma - Results of a phase II trial
    Dragovich, Tomislav
    Burris, Howard, III
    Loehrer, Patrick
    Von Hoff, Daniel D.
    Chow, Sherry
    Stratton, Steven
    Green, Sylvan
    Obregon, Yrma
    Alvarez, Irene
    Gordon, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 157 - 162
  • [30] TH-302 plus gemcitabine (G plus T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC)
    Ryan, David P.
    Reddy, Shantan G.
    Bahary, Nathan
    Uronis, Hope Elizabeth
    Sigal, Darren
    Cohn, Allen Lee
    Schelman, William R.
    Stephenson, Joe
    Eng, Clarence
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345